Less than half of the patients survive more than 5 years overall, while more than half of the patients can survive more than 5 years for some isolated hepatocellular carcinoma with diameter <5 cm. Generally, how long liver cancer can live depends on the stage of tumor, whether the treatment plan is tolerated, and the severity of combined complications.1. Tumor stage: early stage liver cancer can usually achieve a long survival time after active treatment, with 40%-80% of patients surviving for more than 5 years; mid-stage liver cancer patients are prone to recurrence after treatment, but can still achieve a relatively good prognosis. For advanced hepatocellular carcinoma with distant metastasis or serious complications, the prognosis is usually poor, and some reports suggest that the survival period is about 3-6 months; 2. Treatment options: usually surgical resection is one of the generally accepted treatment methods and one of the means with high survival rate, but it is not applicable to all patients. If the patient's physical indications do not tolerate surgery and can only receive other treatments, such as local destruction therapy, hepatic artery chemoembolization, radiation therapy and other modalities, the survival rate of such treatment modalities is lower than that of surgical treatment. Therefore, if the patient can undergo surgery after doctor's evaluation, it is recommended to prefer surgical treatment, supplemented by chemotherapy, radiotherapy and targeted therapy after surgery, in order to prolong the patient's life as much as possible and minimize the impact on the patient's normal life; 3. Complications: How long a patient with liver cancer can live is also related to the existence of complications, such as the patient's combined hepatic encephalopathy, upper gastrointestinal bleeding, bleeding from liver cancer nodes, secondary infection Therefore, patients with liver cancer, no matter what kind of treatment they receive, need to review their medical checkups regularly after treatment to prevent complications.